Statins and heart attack
This article was originally published in The Tan Sheet
Executive Summary
Administering a statin to a heart attack patient within 24 hours of hospitalization "was associated with a substantially decreased risk of in-hospital mortality compared with no statin use (4.0% vs. 15.4%)," Gregg Fonarow, MD, UCLA, et al., report in the September American Journal of Cardiology. Data was collected from 174,635 heart attack patients in 1,230 U.S. hospitals from July 2000 to January 2002. Patients already on statin therapy who were given the drugs upon arrival at the hospital for heart attack treatment also had reduced risk of the event being fatal, the authors found. Those who previously took statins but were not treated with them upon arrival had a slight increase in mortality risk. Statins raise levels of nitric oxide, which possibly reduces inflammation due to heart attacks, Fonarow et al. postulate...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.